Materialise strengthens a unique position in Healthcare


Materialise NV (NASDAQ: MTLS) is a world leader in the development of technology enabling personalized healthcare solutions. Materialise’s latest patent, accepted by the Australian Patent Office, concerns Materialise’s 3D planning technologies and 3D-printed guides which enable the design of screw placements for the fit and fixation of customized implants. With the recent expansion of its portfolio of medical patents, Materialise continues to strengthen its unique position in the healthcare industry, supporting its commitment to help patients worldwide through technological innovation.

Materialise has been transforming the field of personalized medicine for years, providing a full spectrum of personalized solutions for surgeons and hospitals, including 3D-printed guides, which surgeons use to perform highly accurate cutting and drilling during surgery, as well as 3D-printed implants and pre-surgical planning software. Complex cases, such as when a patient undergoes cranio-maxillofacial surgeries to correct deformities or traumas where surgeons need to plan the surgery in 3Dbeforehand, can sometimes only be helped with a personalized solution.

Materialise is committed to expanding new and innovative technology together with local surgeons in the field of healthcare.